Rose Sharon Shabet's Net Worth
$2.08 Billion
Who is Rose Sharon Shabet?
Rose Sharon Shabet has an estimated net worth of $2.08 Billion. This is based on reported shares across multiple companies, which include Amylyx Pharmaceuticals, Inc., Adaptive Biotechnologies Corp, Zentalis Pharmaceuticals, Inc., RayzeBio, Inc., Inhibrx, Inc., Arbutus Biopharma Corp, Myovant Sciences Ltd., Roivant Sciences Ltd., PROCEPT BioRobotics Corp, BridgeBio Pharma, Inc., 4D Molecular Therapeutics, Inc., Ginkgo Bioworks Holdings, Inc., APi Group Corp, FIGS, Inc., Urovant Sciences Ltd., Axovant Gene Therapies Ltd., Rallybio Corp, and Frazier Lifesciences Acquisition Corp.
SEC CIK
Rose Sharon Shabet's CIK is 0001711393
Past Insider Trading and Trends
2019 was Rose Sharon Shabet's most active year for acquiring shares with 72 total transactions. Rose Sharon Shabet's most active month to acquire stocks was the month of May. 2022 was Rose Sharon Shabet's most active year for disposing of shares, totalling 22 transactions. Rose Sharon Shabet's most active month to dispose stocks was the month of August. 2022 saw Rose Sharon Shabet paying a total of $312,238,236.29 for 300,884,319 shares, this is the most they've acquired in one year. In 2020 Rose Sharon Shabet cashed out on 19,163,712 shares for a total of $573,887,078.58, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Amylyx Pharmaceuticals, Inc. (AMLX) Snapshot price: $15.51
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -10.26% | -1.40M |
$29.80 | -$41,719,639.31 | 12.24M |
Sep 8 - Sep 9
| |||
Form 4
|
∞
| 7.17M |
$19.00 | $43,700,000.00 | 7.17M |
Jan 11 - Nov 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Adaptive Biotechnologies Corp (ADPT) Snapshot price: $3.83
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -3.23% | -1.00M |
$55.65 | -$55,650,000.00 | 29.99M |
Dec 14
| |||
Form 4
| -7.46% | -2.50M |
$49.52 | -$123,787,500.00 | 30.99M |
Nov 11
| |||
Form 4
| -7.46% | -2.50M |
$49.52 | -$123,787,500.00 | 30.99M |
Nov 11
| |||
Form 4
| -12.79% | -4.91M |
$24.98 | -$122,706,039.29 | 33.49M |
Jan 28
| |||
Form 4
| -12.79% | -4.91M |
$24.98 | -$122,706,039.29 | 33.49M |
Jan 28
| |||
Form 4
| +2,595.20% | 36.98M |
$20.00 |
—
| 38.41M |
Jul 1
| |||
Form 4
| +2,595.20% | 36.98M |
$20.00 |
—
| 38.41M |
Jul 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Zentalis Pharmaceuticals, Inc. (ZNTL) Snapshot price: $11.35
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -11.25% | -500.00K |
$50.50 | -$25,250,000.00 | 3.94M |
Dec 1
| |||
Form 4
| +19.50% | 725K |
$18.00 | $13,050,000.00 | 4.44M |
Apr 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
RayzeBio, Inc. (RYZB) Snapshot price: $62.18
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -6.64M |
—
|
—
|
0
|
Feb 26
| |||
Form 4
| -100.00% | -6.64M |
—
|
—
|
0
|
Feb 26
| |||
Form 4
|
∞
| 6.64M |
$18.00 |
—
| 6.64M |
Sep 19
| |||
Form 4
|
∞
| 6.64M |
$18.00 |
—
| 6.64M |
Sep 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Inhibrx, Inc. (INBX) Snapshot price: $38.94
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -7.15M |
$30.00 | -$214,524,780.00 |
0
|
May 30
| |||
Form 4
|
∞
| 511.63K |
$19.35 | $9,899,982.45 | 511.63K |
Aug 28
| |||
Form 4
| +93.42% | 1.33M |
$30.00 | $39,999,856.67 | 2.76M |
Oct 7
| |||
Form 4
| +14.45% | 180.22K |
$18.92 | $3,409,865.52 | 1.43M |
Aug 26
| |||
Form 4
| +11.78% | 131.47K |
$19.39 | $2,548,687.94 | 1.25M |
Aug 24 - Aug 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |